1273560

Tejinder Glamour, M.D. — FEI 3036830170

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 17, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pinellas Park, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272721 CFR 312.64(b)Safety Reports - Serious Events
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance